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Summary Age distributions of parents at birth of patients registered in the National Wilms' Tumour Study
were compared to those of the general population. An increasing incidence of sporadic Wilms' tumour with
increasing paternal age was found, with a relative risk of 2.1 of tumour in children of fathers over 55
compared to children of fathers younger than 20. A similar effect for maternal age was found, with a relative
risk of 1.4 in children of mothers over 40 compared to children of mothers younger than 20. The maternal age
effect was much weaker among patients registered later in the study; in the later, more completely ascertained
cohort, parternal age appears to be the major contributor to the parental age effect. Little difference in
paternal age distribution was found between patients with bilateral and unilateral tumour and between male
and female patients. In contrast, patients with reported associated congenital anomalies, patients with evidence
ofnephrogenic rests, and patients with early or late age-of-onset of tumour had parents who were, on average,
substantially older than the remainder. These findings lend support to the idea that many Wilms' tumours
result from new germline mutations. Further, the histologic composition of such tumours may be sufficiently
distinct as to provide a valuable diagnostic indicator of the etiology of these tumours.
Despite recent advances in the genetics and molecular
biology of Wilms' tumour, important questions about the
etiology of this childhood renal neoplasm remain. One such
question concerns the role played by new germline mutation
in a parent. If some sporadic Wilms' tumours result from
new mutation in a parent and if the rates of such mutation
increase with increasing parental age, then parents of Wilms'
patients should be older on average than parents of children
in the general population. Parental age effects have been
previously observed for a number of other tumours, includ-
ing bilateral retinoblastoma (e.g. Pellie et al., 1973) and
neurofibromatosis (e.g. Riccardi et al., 1984).
If parental age is found to be a risk factor for Wilms'
tumour, then the next step is the identification of subtypes of
cases most likely to be the result of new germinal mutation in
a parent. Patients with bilaterial tumour and/or congenital
anomalies, such as aniridia, genitourinary anomalies, Beck-
with-Wiedemann syndrome and hemihypertrophy, but no
family history of either Wilms' tumour or these congenital
anomalies, are candidates for the presence of new germline
mutation because the presence of multiple defects suggests an
event early in development. Patients with nephrogenic rests
are also potential candidates because events associated with
these rests are believed to occur early in development (Beck-
with et al., 1990). If these subtypes of patients are associated
with new germinal mutation, then parents of these patients
should be older on average than parents in the general
population.
The observation of preferential loss of maternal alleles
from the short arm of chromosome 11 (1 lp) in tumours that
show loss of heterozygosity (Mannens et al., 1988; Pal et al.,
1990; Coppes et al., 1992) implies that primary mutation on
lip preferentially occurs on the paternally derived chromo-
some and suggests that the paternally derived allele is more
mutable than the maternal one (Huff et al., 1990; Coppes et
al., 1992). To investigate whether germinal mutations are
seen with equal frequency in maternally vs paternally inherit-
ed chromosomes, Huff et al. (1990) examined the parental
origin of eight cases of de novo constitutional deletions of
1lpl3 and found that seven were of paternal origin. The
preponderence of paternally derived de novo mutations may
be due to an increased germinal mutation rate in males
(Vogel & Rathenberg, 1975). This hypothesis predicts a small
linear increase in the relative incidence of Wilms' tumour
with paternal age, but not with maternal age (Risch et al.,
1987).
A related question concerns the mechanisms of tumour
development. The 'two-hit' model of carcinogenesis, so suc-
cessful in explaining the development of retinoblastoma, has
also been proposed as an explanation for the development of
Wilms' tumour (Knudson & Strong, 1972). Under the two-
hit model, carcinogenesis proceeds only when both copies of
a regulatory gene are independently mutated (Comings,
1973). If one of these mutations occurs in the germline of a
parent, then only one somatic mutation is necessary to pro-
duce a tumour and early-onset bilateral tumour is the pre-
dicted outcome. If the incidence of new mutations increases
with parental age, parents of patients with sporadic bilateral
Wilms' tumour should be older on average than parents of
patients with sporadic unilateral disease, as has been observ-
ed for sporadic bilateral retinoblastoma (Pellie et al., 1973).
In this study, we compared the parental age distributions
of patients from the National Wilms' Turmour Study
(NWTS) to that of the general United States population. We
also examined subgroups of cases to determine if particular
diagnostic or histologic factors contributed to observed
parental age effects. Of particular interest were cases with
bilateral tumour or with an associated congenital anomaly,
as these conditions may be indicators of new germline muta-
tion. In addition, we separately examined patients with the
histologic finding of intralobar or perilobar nephrogenic
rests, as these precursor lesions are thought to be indicative
of the embryonic stage at which tumorigenesis begins (Beck-
with et al., 1990).
Materials and methods
The NWTS, a collaborative effort of the Children's Cancer
Study Group and Pediatric Oncology Group institutions,
currently registers an estimated 70% of all cases of Wilms'
tumour diagnosed annually in the United States (Gloeckler,
1992). All NWTS cases diagnosed between 1969 and 1987
that met the following criteria were included: (1) US born;
(2) white, including Hispanic; (3) no known family history of
Wilms' tumour; (4) birthdates available for patient and both
natural parents. Non-whites were excluded from the analysis
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because of their smaller numbers and higher proportion of
missing paternal ages. Hispanics were included because US
census data includes Hispanics in the category White.
Patients were considered to have a family history of Wilms'
tumour if a family's report of tumour in any blood relative,
up through fifth degree relatives, was subsequently confirmed
by pathology report.
The observed parental age distribution was constructed as
follows. First, the maternal and paternal age axes were parti-
tioned into 5-year intervals consistent with those used by the
Vital Statistics of the United States. Maternal age was divid-
ed into eight intervals (less than 15, 15-19, . . . , 45 or older)
and paternal age into nine intervals (less than 20, 20-24, . . ..
55 or older). Next, the ages of the natural parents at the time
of birth of the patient were calculated. Finally, a two-way
cross-classification of maternal by paternal age was con-
structed by assigning each case to the appropriate cell.
Using census data on whites from the Vital Statistics ofthe
United States, the expected joint distribution of paternal and
maternal age was constructed by weighting the counts from
the appropriate census year by the proportion of NWTS
cases born in that year. Expected numbers in each parental
age category were computed by normalising the distribution
of the total number of Wilms' tumour cases.
Marginal observed and expected counts were obtained by
summing over the appropriate row or column of the two-way
table. If a cell of one of the marginal tables contained an
expected count smaller than two, that cell was combined with
an adjacent cell. Marginal relative risks were obtained by
taking the ratio of the marginal observed and expected
counts (O/E) and dividing by O/E for the lowest age
category.
Similar methods were used to compute observed and
expected counts for the marginal maternal and paternal age
distributions of subgroups determined by these criteria:
(1) male or female; (2) bilateral or unilateral tumour;
(3) Beckwith-Wiedemann syndrome and/or hemihypertrophy,
aniridia, cryptorchidism and/or hypospadias without aniridia,
other genitourinary anomalies without aniridia, or no con-
genital anomaly; (4) intralobar nephrogenic rests, perilobar
nephrogenic rests without intralobar rests, or no nephrogenic
rests, (5) early (younger than 2 years), middle (2 to 3 years),
late (4 to 9 years), or extreme (10 years or older) age-of-onset
of tumour, and (6) registration from 1969 to 1978 or from
1979 to 1987. Only patients with synchronous bilateral
tumour were included in the bilateral group. All patients not
included in one of the four anomaly categories were included
in the no congenital anomaly category.
Pearson's chi-squared statistic (Rao, 1965) was used to
compare observed and expected counts in the marginal
tables. In addition, a Z-statistic which compared the observ-
ed and expected mean ages was also computed. Expected
mean ages AE were computed by weighting the midpoint Ai
of each age interval i by the proportion pi of expected births
in that interval (i = 1, . . , K). Intervals that included the
upper or lower tails of the distributions were assigned 'mid-
points' 2.5 years above or below the nearest cutpoint, respec-
tively. Observed mean ages Ao were computed in a similar
fashion. Expected variances were similarly computed using
the formula
k
VE = p Pi (Ai-AE)2
i= 1
so that Z = (AO -AE)/VVEIN, where N is the sample size. Z
is normally distributed in large samples even if the parental
age distribution is not normal. For small sample sizes, a
Wilcoxon signed-rank test was also performed and gave
similar results. Because of our prediction that parents of
Wilms' tumour patients are older than those in the general
population, a one-sided test of hypothesis was employed.
Poisson regression (McCullagh & Nelder, 1990) was used
to examine the combined effects ofmaternal and paternal age
on tumour incidence. For this analysis, parental age distribu-
tions were partitioned into intervals as described in the begin-
ning of this section. A multiplicative model was fit to the
data and expected numbers of cases in each joint interval
were used as 'offsets' in the analysis. Likelihood ratio criteria
were employed to test for the linear contribution of maternal
(paternal) age after paternal (maternal) age was taken into
account. Analysis of covariance was used to test for differ-
ences in parental age between subgroups, after adjusting for
year of birth and year of diagnosis; these analyses were
performed separately for maternal and paternal age. Multiple
comparisons were performed using Tukey's studentised range
test (Neter et al., 1985).
Results
Of the 4,117 NWTS patients registered from 1969 through
1987, 3,054 were white, born in the US and had no confirm-
ed family history of Wilms' tumour. Paternal age was missing
for an additional 600 patients (19.6%) and maternal age for
an additional 17 patients, resulting in a final total of 2,437
NWTS patients for the analysis. For the census data, ages
were missing for only about 6% of fathers. We assume that
the difference reflects additional data missing at random with
respect to paternal age. Because census data were unavailable
for 1940, 1957, 1958, 1967 and 1968, for the purpose of
computing the expected parental age distribution, 42 patients
born in 1967 were assumed to have been born in 1966, 70
patients born in 1968 were assumed to have been born in
1969, two patients born in 1957 and 1958 were assumed to
have been born in 1959 and one patient born in 1940 was
assumed to have been born in 1947.
Marginal observed and expected counts, along with ratios
of observed to expected, are given in Table I. Because the
expected number of mothers younger than 15 and older than
45 were less than 2 (1.78 and 1.20 respectively), the data in
these two cells were combined with those of their respective
nearest intervals. Four mothers were younger than 15 and
two were older than 45. The Pearson's chi-square statistics
and the Z tests comparing observed and expected mean ages
suggest a somewhat stronger effect for maternal age.
A plot of paternal age vs O/E is shown in Figure 1. For
paternal age, O/E increases gradually for young and middle
age categories, then more rapidly at older ages. For maternal
age, the increase is gradual over the range of age. To exclude
the possibility that only the highest age categories contribute
to the age effect, a one-tailed Z-test was performed after
excluding the highest two paternal age categories and was
significant (Z = 2.40, P = 0.008). A similar test excluding the
highest maternal age category was also significant (Z = 2.96,
P = 0.002).
Observed and expected counts for the two-way cross-classi-
fication of maternal by paternal age categories are given in
Table II. Examination of the table suggests that, within most
levels of maternal age, O/E increase with paternal age.
Similarly, within most levels of paternal age, O/E increases
with maternal age. These results suggest that neither mater-
nal nor paternal age alone could explain the deviations of the
observed from the expected counts. This question was further
examined using Poisson regression. Because of the high
correlation between maternal and paternal age, it was not
possible to separate the effect of paternal age from that of
maternal age.
Results of the subgroup analysis are shown in Table III. A
small increase in mean parental age in females is noted.
However, analysis of covariance failed to find significant
differences between the two groups in either maternal or
paternal age; this result is not surprising given the lower
power of such an internal analysis compared to the external
analysis shown in Table III. Of the 2,437 study cases, nine
were missing the indicator for laterality; of the remainder,
132 (5.4%) had bilateral tumour. Although the differences
between observed and expected mean parental age appear
smaller for the bilateral than for the unilateral group, the
differences in the bilateral group are likely to be quite vari-
able due to the much smaller sample size. Analysis of covari-WILMS' TUMOUR AND PARENTAL AGE 815
Table I Observed (0) and expected (E) counts for marginal parental age distributions
Counts' Mean
<20 20-24 25-29 30-34 35-39 40-44 45-49 50-54 >55 age_
0 102.00 569.00 862.00 539.00 236.00 82.00 27.00 11.00 9.00 28.94
E 106.91 632.54 836.25 528.20 216.09 77.67 26.15 8.73 4.45 28.57
O/E 0.95 0.90 1.03 1.02 1.09 1.06 1.03 1.26 2.02
= 14.97, P = 0.060. bZ= 2.89, P = 0.002 (one-tailed).
Maternal age
Counts' Mean
<20 20-24 25-29 30-34 35-39 ;¢40 Ageb
0 243.00 821.00 844.00 381.00 121.00 27.00 26.26
E 296.00 841.50 789.96 373.62 112.55 23.37 25.93
O/E 0.82 0.98 1.07 1.02 1.08 1.16













Figure 1 Ratio of observed to expected counts as a function of parental age.
ance failed to find significant differences between the groups
when they were compared directly.
Seventy-five (3.1%) of the study cases reported Beckwith-
Wiedemann syndrome and/or hemihypertrophy; 18 (0.7%)
reported aniridia with or without other anomalies; an addi-
tional 64 (2.6%, 5.3% of males) reported cryptorchidism
and/or hypospadias; and a further 165 (6.8%) reported other
genitourinary anomalies. Sizeable differences between observ-
ed and expected ages for mean maternal and paternal age,
respectively, were found in most of the anomaly subgroups.
A significant and striking increase of almost 2 years in mean
paternal age above population expectation was found in
patients with cryptorchidism and/or hypospadias. A signifi-
cant increase of almost 1 year in mean maternal age was
found in patients with other genitourinary anomalies. As in
the previous analysis, the small sample sizes in these groups
suggests caution in interpreting the results, which are likely
to be quite variable. The lack of significance of some of the
effects may well be due to the small sample sizes rather than
a real lack of difference. Analysis of covariance failed to
detect significant differences between these groups in the
internal comparison.
Of the 1,234 cases that provided sufficient tumour material
to detect the presence of nephrogenic rests, intralobar rests
were found in 175 (14.2%). A large and significant differ-
ences of over 1 year between observed and expected mean
paternal age was found as well as moderate effect for mater-
nal age. Perilobar nephrogenic rests were found in 233 of the
remaining 1,059 patients. Moderate differences in mean
parental age were found for these patients. Analysis of
covariance, however, failed to detect significant differences
between the groups in the internal comparison.
Patients were also divided into subgroups according to the
age of the patient at the time of diagnosis of the tumour.
Significant differences between observed and expected paren-
tal ages were found for the early and late age-of-onset group.
Large differences were also noted in the extreme age-of-onset
group. After combining the extreme and late groups, signifi-
cant differences between the age-of-onset groups were detect-
ed using analysis of covariance (maternal: F2,2421 = 5.65, P =
0.0036; paternal: F2,2421 = 3.14, P = 0.0433). Subsequent mul-
tiple comparison procedures detected significant differences
between the middle and early and between the middle and
late groups, but not between the early and late groups.
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Table II Observed (0) and expected (E) counts for two-way cross-classification of maternal and paternal age
Maternal Paternal age
age <20 20-24 25-29 30-34 35-39 40-44 45-49 50-54 >55
<20 0 86.00 119.00 30.00 6.00 2.00 0.00 0.00 0.00 0.00
E 90.42 167.64 29.37 5.89 1.69 0.58 0.24 0.10 0.08
O/E 0.95 0.71 1.02 1.02 1.18 0.00 0.00 0.00 0.00
20-24 0 15.00 393.00 331.00 59.00 18.00 1.00 1.00 3.00 0.00
E 15.42 414.34 326.97 62.75 14.84 4.60 1.59 0.62 0.37
O/E 0.97 0.95 1.01 0.94 1.21 0.22 0.63 4.87 0.00
25-29 0 1.00 50.00 452.00 266.00 52.00 14.00 8.00 0.00 1.00
E 0.88 44.92 434.04 243.41 48.24 12.30 3.99 1.41 0.78
O/E 1.14 1.11 1.04 1.09 1.08 1.14 2.01 0.00 1.29
30-34 0 0.00 7.00 45.00 190.00 102.00 24.00 5.00 4.00 4.00
E 0.15 4.75 41.21 199.00 96.42 22.24 6.43 2.26 1.13
O/E 0.00 1.47 1.09 0.95 1.06 1.08 0.78 1.77 3.54
35-39 0 0.00 0.00 4.00 15.00 58.00 31.00 10.00 3.00 0.00
E 0.04 0.78 4.23 16.02 51.74 28.19 7.84 2.46 1.26
O/E 0.00 0.00 0.94 0.94 1.12 1.10 1.28 1.22 0.00
40 0 0.00 0.00 0.00 3.00 4.00 12.00 3.00 1.00 4.00
E 0.01 0.10 0.43 1.12 3.16 9.77 6.06 1.87 0.84
O/E 0.00 0.00 0.00 2.68 1.27 1.23 0.49 0.53 4.78
Table III Observed and expected mean ages for various subgroups
Sample Paternal Maternal
Subgroup size Observed Expected O-E (Std Err) Observed Expected O-E (Std Err)
Entire sample 2437 28.94 28.57 0.38b (0.13) 26.26 25.93 0.33b (0.11)
Male 1197 28.89 28.59 0.30a (0.18) 26.19 25.95 0.24 (0.16)
Female 1240 28.99 28.56 0.43b (0.18) 26.33 25.92 0.41b (0.15)
Unilateral 2296 28.94 28.57 0.37b (0.11) 26.26 25.92 0.34b (0.11)
Bilateral 132 28.83 28.63 0.20 (0.54) 26.25 26.02 0.23 (0.47)
No anomaly 2115 28.85 28.57 0.29a (0.12) 26.20 25.93 0.27 (0.11)
B-W/Hemihypertrophy 75 29.30 28.49 0.81 (0.73) 26.23 25.84 0.39 (0.62)
Aniridia 18 29.17 28.60 0.56 (1.48) 25.83 25.96 -0.12 (1.27)
Cryptorchidism/Hypospadias 64 30.55 28.68 1.86b (0.78) 27.03 26.09 0.94 (0.67)
Other GU 165 29.20 28.58 0.61 (0.49) 26.83 25.93 0.918 (0.42)
No rest 826 28.73 28.63 0.10 (0.21) 26.17 26.06 0.11 (0.18)
Intralobar±perilobar 175 30.01 28.94 1.07a (0.46) 26.99 26.40 0.58 (0.40)
Perilobar alone 233 29.05 28.66 0.38 (0.40) 26.56 26.10 0.45 (0.35)
Early age-of-onset 807 29.18 28.71 0.47a (0.22) 26.47 26.12 0.34a (0.19)
Middle age-of-onset 786 28.42 28.52 -0.10 (0.22) 25.77 25.89 -0.12 (0.19)
Late age-of-onset 769 29.14 28.46 0.67b (0.23) 26.55 25.78 0.77b (0.20)
Extreme age-of-onset 75 29.70 28.76 0.94 (0.78) 26.30 25.84 0.46 (0.66)
1969-78 cohort 803 28.84 28.40 0.448 (0.23) 26.26 25.61 0.65b (0.20)
1979-87 cohort 1634 28.99 28.66 0.33a (0.15) 26.26 26.09 0.18 (0.13)
ap<0.05 (one-tailed Z test). bp<0.01 (one-tailed Z test). Note: Z-test compares observed mean age to the mean age of the
population.
Finally, patients were divided into two groups based on
year of diagnosis. Surprisingly, a large and significant differ-
ence between observed and expected maternal age was
observed for the 1969-78 cohort but not for the 1979-87
cohort. Significant differences between observed and expected
paternal age were observed in both cohorts. In addition,
Poisson regression analysis ofthe 1979-87 cohort shows that
paternal age accounts for most of the deviation of observed
from expected ages in this cohort; when paternal age is
accounted for, there is no difference between observed and
expected mean maternal age. Subgroup analysis of the 1979-
87 cohort shows results similar to those in Table III, with the
notable exception that no parental age differences are found
in the early age-of-onset group.
Multiple linear regression analysis was performed to deter-
mine if the effect of parental age on any variable could be
substantially altered by accounting for the remaining vari-
ables. The results (not shown) suggest that congenital anoma-
lies, nephrogenic rests and age-of-onset each make separate
contributions, suggesting that these three variables may con-
tribute to the variability in parental age through different
mechanisms.
Discussion
The present study demonstrates a positive relationship
between parental age and incidence of sporadic Wilms'
tumour, suggesting that at least some Wilms' tumours are the
result of new germline mutations in a parent. It should be
noted here that ascertainment of US Wilms' tumour cases by
the NWTS is not complete. Unascertained cases generally fall
in geographical areas served by institutions that do not par-
ticipate in the NWTS; it is possible that geographical
differences in parental age distributions exist which might
bias the results.
The difference between the early and late cohorts in the
difference between observed and expected maternal age is
difficult to explain. One possibility is that the difference
observed in the early cohort is an artifact due to sampling
bias; it may be that, for whatever reason, older mothers were
preferentially included in the NWTS in its early years. The
ascertainment probability in the early cohort is 0.37, roughly
half that of the later cohort (0.67). On the other hand, the
difference may conceivably have been the results of some
biological mechanism, such as environmental exposure that isWILMS' TUMOUR AND PARENTAL AGE 817
no longer present.
The late cohort is perhaps the more relevant, as it is the
more completely ascertained. In this cohort, paternal rather
than maternal age is the more important contributor to the
parental age effect. This finding is supported by the results of
Huff et al. (1990), which demonstrate the paternal origin of
seven out of eight Wilms' tumour cases with de novo consti-
tutional deletions of chromosome llpl3. Risch et al. (1987)
proposed both linear and exponential 'copy-error' models of
paternal mutagenesis and applied them to data on 17 domin-
ant diseases. For diseases displaying a low rate of increase of
O/E, they found that (1) both exponential and linear models
fit the data equally well, and (2) results were compatible with
mutation occurring primarily in males. The size of the effect
in the present study is comparable to those in the low-rate-
of-increase group of diseases discussed by Risch et al. (1987).
The fact that sporadic bilateral Wilms' tumour has earlier
average age-of-onset than unilateral tumour (Breslow et al.,
1988) is a key tenet of the Knudson-Strong two-hit hypothe-
sis. This study provides no evidence, however, that parents of
children with bilateral tumour tend to be older than those of
children with unilateral tumour, suggesting that bilateral
tumours are no more likely to be the result of new germline
mutation in a parent than unilateral tumour. This failure to
confirm the predictions of the two-hit model stands in sharp
contrast to the finding of Pellie et al. (1973) that fathers of
patients with sporadic bilateral retinoblastoma are more than
1.2 years older, on average, than father in the general popu-
lation, while fathers of sporadic unilateral retinoblastoma
patients do not differ in average age from fathers in the
general population. A similar but less striking result was
found for maternal age. This result that lends support to the
Knudson-Strong two-hit hypothesis in the case of retinoblas-
toma is absent in the case of Wilms' tumour.
Evidence is found that parental ages of patients with at
least some associated congenital anomalies are higher than
expected. Also, parents of patients with rest-associated
tumours are substantially older than parents of the remaining
patients. In particular, fathers of patients with intralobar
nephrogenic rests are, on average, more than a year older
than expected, fathers of patients with cryptorchism and/or
hypospadias are almost 2 years older than expected, and
mothers of patients with other genitourinary anomalies are
almost 1 year older than expected. This combination of
patient/tumour characteristics is associated with mutations in
the IIpi3 region (e.g. Pelletier et al., 1991; Pritchard-Jones &
Fleming, 1991) and suggests that many tumours which
involve mutations to the WT1 gene may be the result of new
germinal mutations.
The observation of a parental age effect for early age-of-
onset patients is not surprising, as patients with intralobar
nephrogenic rests and/or genitourinary anomalies or aniridia
tend to have early age-of-onset (Breslow et al., 1988). How-
ever, patients with perilobar nephrogenic rests and/or Beck-
with-Wiedemann syndrome or hemihypertrophy do not differ
in age-of-onset distribution from the main body of patients
(Breslow et al., 1988). The presence of strong parental age
differences in late age-of-onset patients may be indicative of
the presence of a subtype of Wilms' tumours other than
those associated with Beckwith-Wiedemann syndrome and
genitourinary anomalies and aniridia.
It has been hypothesised that the presence of nephrogenic
rests reflect events early in development (Beckwith et al.,
1990). In particular, the presence of intralobar nephrogenic
rests are believed to indicate an earlier developmental distur-
bance than the presence of perilobar nephrogenic rests. The
finding of parental age effects in these subgroups suggests
that some of the relevant events occur prior to conception. If
so, routine identification of rest-associated disease may prove
to be helpful in diagnosis of the etiologic origin of Wilms'
tumours and, consequently, assessment of risk to relatives of
patients. A better understanding of these issues will come
from a study of the increasing numbers of survivors and their
offspring. Two such studies (Li et al., 1987; Mulvihill et al.,
1987) have found only one case of Wilms' tumour among
225 offspring of childhood kidney tumour survivors. It is
hoped that continued follow-up of the large NWTS series,
with its increasing numbers of survivors approaching the
childbearing years, will help resolve some of these issues.
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